Header Logo

Connection

WEI HU to Recombinant Fusion Proteins

Back to Details
This is a "connection" page, showing publications WEI HU has written about Recombinant Fusion Proteins.
WEI HU
Connection Strength
0.073
Recombinant Fusion Proteins
  1. A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 Dec; 127(3):538-43.
    View in: PubMed
    Score: 0.073
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.